ArticleQuantitative imaging in medicine and surgery2026
Integrating central-slice anatomy and MRF-mapped radiomics dynamics for lung adenocarcinoma subtyping.
Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- A methodological framework for integrating generalisable deep learning and radiomics fusion model for early lung cancer detection across multi-centre imaging datasets.BMC medical informatics and decision making · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lung adenocarcinoma is a leading subtype of lung cancer, and accurate subclassification is critical for guiding clinical management. However, existing computed tomography (CT)-based approaches often fail to capture how lesion characteristics evolve across adjacent slices. This study aims to address this gap by integrating central-slice anatomy with dynamic radiomics information. Methods: In this multi-center retrospective study, CT lesions were allocated into training, internal testing, and external validation cohorts. For each lesion, a 64×64 patch from the automatically selected central slice (IMG1) and a multi-layer radiomic sequence derived from PyRadiomics descriptors were extracted. After feature filtering and least absolute shrinkage and selection operator (LASSO) selection, 14 key descriptors were arranged slice-by-slice and modeled with a BiLSTM-Attention network. The resulting temporal representation was transformed into a two-dimensional Markov Random Field (MRF) map and fused with IMG1 to form a dual-channel input for the proposed dynamic radiomics fusion network (DRFN). DRFN was compared with two baselines: a convolutional neural network (CNN) using only IMG1 and a BiLSTM-Attention model using only radiomics sequences. Performance was assessed using area under the curve (AUC), accuracy, precision, recall, and F1-score, and interpretability was explored with class activation mapping (CAM). Results: On an independent test cohort, DRFN achieved per-class AUCs of 0.97 (minimally invasive adenocarcinoma), 0.99 (adenocarcinoma in situ), and 0.95 (invasive adenocarcinoma). Grad-CAM heatmaps confirmed that DRFN consistently attended to lesion cores, spiculated margins, and adjacent vascular structures-mirroring radiologists' diagnostic reasoning. Compared to a single-channel CNN (AUCs: 0.77-0.88) and a BiLSTM-Attention-only model (AUCs: 0.88-0.94), DRFN demonstrated superior sensitivity, specificity, and generalizability. Conclusions: By fusing static anatomical information with dynamic radiomics evolution maps, DRFN offers both high classification accuracy and transparent interpretability. Our framework thus holds promise as an intelligent diagnostic aid for lung adenocarcinoma subtyping in clinical practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.